USPHNYSEServices-Health ServicesFiscal year ends December 31

U S PHYSICAL THERAPY INC /NV

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$83.91−1.80 (-2.10%)

Close on Oct 19, 2026

Market cap: $1.26B
P/E (TTM): 59.1
Dividend yield: 2.15%

U S PHYSICAL THERAPY INC /NV cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Depreciation & Amortization	22	19	16	15	12	11	10	9.76	9.71	8.78	7.95	6.74	5.56	5.29	5.45	5.67	5.90
Stock-Based Compensation	8.27	7.82	7.24	7.26	7.87	7.92	6.99	5.94	5.03	4.96	4.49	3.36	2.74	2.10	2.03	1.29	1.57
Deferred Income Taxes	11	4.87	4.65	12	5.69	-0.26	4.65	4.81	-4.86	2.98	5.95	5.11	2.37	3.74	3.83	0.45	0.71
Change in Accounts Receivable	-12	-5.35	-5.65	-10	-9.42	0.90	-6.38	-3.43	-3.45	-3.28	-5.52	-5.39	-5.39	–	–	–	–
Change in Accounts Payable	-7.80	1.71	0.02	-7.76	4.66	12	-4.21	4.88	6.98	2.99	-7.01	1.87	4.83	-0.34	1.19	-0.29	0.60
Operating Cash Flow	75	75	82	59	76	100	62	73	57	51	38	41	45	39	33	31	31
Capital Expenditures	-14	-9.19	-9.29	-8.25	-8.20	-7.64	-10	-7.19	-7.10	-8.26	-6.26	-5.17	-4.64	-4.23	-3.22	-3.67	-3.88
Acquisitions	-16	-133	-27	-60	-87	-24	-31	-16	-37	-24	-19	-12	-47	-7.93	-9.45	-18	-1.18
Sale of Property, Plant & Equipment	–	–	–	–	–	–	0.06	0.00	0.08	0.06	0.07	0.05	0.46	0.06	0.01	0.92	0.06
Divestitures	–	–	–	–	0.28	0.84	12	0.00	0	–	–	–	–	–	–	–	–
Other Investing Activities	0.36	0.14	-0.19	0	0	–	–	–	–	–	–	–	–	–	–	–	–
Investing Cash Flow	-37	-149	-45	-81	-124	-51	-38	-24	-44	-32	-26	-18	-52	-14	-32	-22	-7.33
Dividends Paid	-27	-27	-24	-21	-19	-4.11	-15	-12	-10	-8.51	-7.45	-5.87	-4.84	-9.02	-3.79	–	–
Share Repurchases	-5.57	0	0	–	–	–	–	–	–	–	–	–	–	–	-4.66	-1.40	-5.59
Stock Issued	0	0	164	0	0	–	–	–	–	–	–	–	–	–	–	–	–
Debt Issued	–	0	0	150	0	0	–	–	–	–	–	–	–	–	–	–	–
Debt Repaid	-9.38	-3.75	-3.75	-1.88	0	0	–	–	–	–	–	–	–	–	–	–	–
Other Financing Activities	–	0	0	0.01	0.03	0.00	-0.05	-0.04	0.16	0.00	0.01	0.05	0.05	0.08	–	0.42	–
Financing Cash Flow	-44	-37	84	26	43	-39	-24	-48	-11	-14	-9.89	-22	8.88	-23	-0.25	-6.14	-27
Net Change in Cash	-5.79	-111	121	3.03	-4.35	9.37	0.18	1.44	1.89	4.27	1.51	1.37	1.23	1.69	0.80	2.75	-3.68
Free Cash Flow	61	66	73	50	68	92	52	66	49	43	31	36	40	35	29	27	27
Income Taxes Paid	14	4.82	4.93	7.62	12	7.68	9.86	9.18	8.54	11	7.78	9.25	4.11	6.36	9.04	7.80	8.45
Interest Paid	9.43	7.21	8.66	5.69	1.35	1.20	1.89	2.36	2.11	0.78	0.88	1.10	0.35	0.64	0.33	0.18	0.32

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 18.7%
Operating margin: 9.4%
Net margin: 4.0%
Return on equity, FY2025: 8.2%

Financial strength

Current ratio: 1.27
Debt to equity: 0.49
Debt to assets: 17.6%
Cash to current liabilities: 22.6%

Valuation

P/E ratio: 59.1
Price to sales: 1.56
Price to book: 2.82
Dividend yield: 2.15%